Skip to main content

Table 3 Basic information of 71 patients with glioma

From: Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction

Characteristics

n

(%)

Age (years)

 <  = 45

20

28.2

 > 45

51

71.8

Gender

 Male

41

57.7

 Female

30

42.3

WHO grade

 G1

1

1.5

 G2

14

21.5

 G3

17

26.2

 G4

33

50.8

Histological type

 Oligodendrogliomas

6

9.7

 Oligoastrocytomas

7

11.3

 Astrocytoma

16

25.8

 Glioblastoma multiforme

33

53.2

IDH1 status

 WT

27

75

 Mut

9

25

OLIG2

 Negative

5

8.5

 Positive

54

91.5

Ki-67 positive (%)

 < 50

47

72.3

 >  = 50

18

27.7